Get Ready to Hear a Lot More About Your Mitochondria
Robert F. Kennedy Jr.’s warning about mitochondria slipped in between the anti-vaccine junk science and the excoriation of pharmaceutical drugs as “the No. 3 killer in our country.” He was...
Robert F. Kennedy Jr.’s warning about mitochondria slipped in between the anti-vaccine junk science and the excoriation of pharmaceutical drugs as “the No. 3 killer in our country.” He was...
“Data is cleaner throughout all the downstream systems. Our refreshed power reporting now provides encounter-level data, which offers more actionable insights for our client’s operational teams.”-Cindy Biggio, Director of Patient...
By MELISSA LUNARDINI The Rise of Digital Grief Support We’re witnessing a shift in how we process one of humanity’s most universal experiences: grief. Several companies have emerged in recent...
How can an established healthcare leader harness AI to drive innovation, growth, and lasting competitive advantage? In this episode, Stewart Gandolf sits down with Michael Krachon, President of Theragenics, to...
This article is a part of your HHCN+ Membership To sustain margins while meeting growing demand, against a backdrop of payment pressure, at-home care leaders must find ways to operate...
Skip to content XAbout Rama SmartSearchRamaOnHealthcare brings signal to noise to keep you up-to-date with the latest healthcare industry news. We continuously refine our search algorithm to help you quickly and...
Many hospitals and health systems are reaching a tipping point as they struggle to store, organize and leverage an exponentially increasing volume of data.Traditional storage architectures, originally built for limited,...
It’s been a full week’s coverage on food-as-medicine and food as a driver of health in America this week on the Health Populi blog. Today we turn to the chefs...
In partnership with Cost Plus Drugs and Waltz Health, Serve You Rx has added Stelara biosimilars Otulfi and Yesintek to its formulary. The post Serve You Rx Adds 2 Stelara...
FBI Director Kash Patel said in an interview this week that his agency made a "breakthrough" as it continues to investigate former National Institute of Allergy and Infectious Diseases (NIAID)...